1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Anvirzel: new trials by email Literature Review of Anvirzel trials Research Report on Anvirzel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) Carboplatin, Docetaxel, Anvirzel - Chemotherapeutic Agent Toxicity, Lung Cancer | Phase 1 | Withdrawn | M.D. Anderson Cancer Center | 2014-06-01 | 2015-06-08 |
Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
M.D. Anderson Cancer Center (1)